At present, the number of patients with hepatitis B “small three positive” is very high, accounting for about 30% of the total number of hepatitis B patients. In the past, it was thought that the conversion of “major triple-positive” to “minor triple-positive” indicated a weakened viral replication, less infectiousness, and a change for the better, so no treatment was needed. This understanding is one-sided and flawed, and the treatment of “small triplets” must be treated according to the patient’s specific situation. The existence of hepatitis B “small three yang” has two situations, one is that the hepatitis B virus through the regulation of autoimmunity or antiviral treatment, viral replication is reduced or tends to quiescence, which is a good phenomenon; another situation is the result of hepatitis B virus mutation, although it is “small three yang The other situation is the result of the mutation of the hepatitis B virus, although it is “small three positive”, but the viral replication still continues, the disease aggravated, is a bad phenomenon. Therefore, patients with “small three yang” must be treated differently, and the treatment depends on the specific situation. Theoretically, all patients with “small triplets” should be treated. The existence of hepatitis B “small triplets”, in any form, is a potential threat to human health and their timely and thorough removal is indisputable. Some patients with “small triple-positive” have long-term fluctuations in liver function, but do not receive the correct treatment, resulting in the gradual development of the disease, which eventually evolves into cirrhosis. Patients with “small triple yang” need timely treatment when they encounter the following situations. 1, there are obvious symptoms, such as fatigue, loss of appetite, abdominal distension, discomfort in the liver area, etc. 2. Repeated fluctuations in liver function: elevated transaminases, serum bilirubin, lower albumin, etc. 3.People with positive hepatitis B virus deoxyribonucleic acid (HBVDNA) test. The treatment principle is: restoring liver function, anti-virus and stopping liver fibrosis. For the treatment of hepatitis B “small three yang”, do not trust some charlatans, “ancestral secret recipes”, etc., it is likely to spend a waste of money but make the disease worse, so be sure to go to a regular hospital for effective treatment. For the treatment of hepatitis B, small three yang, fatty liver, liver cirrhosis has absolute technical advantages. 1, combined antiviral therapy; 2, reconstruction of the body’s immune system; 3, DC biological therapy; 4, Chinese and Western medicine reversal therapy; 5, bionic immunotherapy. Once again, do not think that hepatitis B “small third” is not serious and ignore the treatment, early treatment to eliminate the potential danger is the most important. And no matter what the situation is, patients with “small triplet” should strengthen the examination and keep abreast of their condition.